The perils of blood thinners: Can the risk be lowered?
Millions of Americans rely on anticoagulants – so-called "blood thinners" that prevent deadly clots from forming in their veins. However, these life-saving medications come with a daunting price tag: an increased risk of serious and sometimes fatal bleeding events.
Larry Bordeaux, 65, credits his blood thinner for saving his life after developing deadly clots following surgery in 2010. Yet, he knows the risks all too well – from gastrointestinal bleeding to uncontrolled nosebleeds. In fact, even a simple fall can be catastrophic if the medication is not taken correctly.
Experts warn that many patients and their families are not adequately informed about the dangers associated with blood thinners. This lack of awareness often leads to preventable harms, with adverse events occurring every day.
The newer generation of direct oral anticoagulants (DOACs) was introduced in 2010, promising to be safer and more consistent than warfarin. However, over a decade later, nearly 300,000 patients taking these medications still end up in emergency rooms each year due to bleeding events.
One major culprit is aspirin, often prescribed alongside blood thinners without proper education for patients. This combination can increase the risk of serious bleeding complications. Furthermore, dosing errors remain a significant issue, particularly when vascular medicine doctors are involved in prescribing and monitoring these medications.
To mitigate this risk, some hospitals have turned to predictive models that help doctors weigh patients' risk of bleeding against their stroke risk. Emerging AI tools may soon aid in identifying the correct dose for each patient, as well as prioritizing those who require specialist care.
While new treatments on the horizon, such as ablation procedures and Factor XIa inhibitors, hold promise, experts emphasize the need to address patient harm linked to blood thinners more effectively. The stakes are high: hundreds of thousands of people and their families suffer from preventable bleeding events every year.
As Dr. Leslie Lake of the National Blood Clot Alliance notes, "Bleeding events aren't rare edge cases; they happen every day." It is time for healthcare providers to reevaluate their approach to blood thinners and prioritize better patient education, more precise dosing, and innovative prevention strategies. Only then can we reduce the risk associated with these life-saving medications and save countless lives in the process.
Millions of Americans rely on anticoagulants – so-called "blood thinners" that prevent deadly clots from forming in their veins. However, these life-saving medications come with a daunting price tag: an increased risk of serious and sometimes fatal bleeding events.
Larry Bordeaux, 65, credits his blood thinner for saving his life after developing deadly clots following surgery in 2010. Yet, he knows the risks all too well – from gastrointestinal bleeding to uncontrolled nosebleeds. In fact, even a simple fall can be catastrophic if the medication is not taken correctly.
Experts warn that many patients and their families are not adequately informed about the dangers associated with blood thinners. This lack of awareness often leads to preventable harms, with adverse events occurring every day.
The newer generation of direct oral anticoagulants (DOACs) was introduced in 2010, promising to be safer and more consistent than warfarin. However, over a decade later, nearly 300,000 patients taking these medications still end up in emergency rooms each year due to bleeding events.
One major culprit is aspirin, often prescribed alongside blood thinners without proper education for patients. This combination can increase the risk of serious bleeding complications. Furthermore, dosing errors remain a significant issue, particularly when vascular medicine doctors are involved in prescribing and monitoring these medications.
To mitigate this risk, some hospitals have turned to predictive models that help doctors weigh patients' risk of bleeding against their stroke risk. Emerging AI tools may soon aid in identifying the correct dose for each patient, as well as prioritizing those who require specialist care.
While new treatments on the horizon, such as ablation procedures and Factor XIa inhibitors, hold promise, experts emphasize the need to address patient harm linked to blood thinners more effectively. The stakes are high: hundreds of thousands of people and their families suffer from preventable bleeding events every year.
As Dr. Leslie Lake of the National Blood Clot Alliance notes, "Bleeding events aren't rare edge cases; they happen every day." It is time for healthcare providers to reevaluate their approach to blood thinners and prioritize better patient education, more precise dosing, and innovative prevention strategies. Only then can we reduce the risk associated with these life-saving medications and save countless lives in the process.